Back 2018 Diabetes Guideline Update: Controversies and New Recommendations This module will review updates to the 2018 American Diabetes Association Standards of Medical Care in Diabetes, and how they are reflected in the D-H Knowledge Map Diabetes Clinical Practice Guideline. Dr. Brackett will discuss controversies about blood pressure and Hgb A1c targets, and present information on SGLT-2 and GLP-1 classes of drugs. Activity Details Start Date: April 12, 2018 End Date: April 12, 2019 Presenter Charles Brackett, MD, MPH Assistant Professor of Medicine, Geisel School of Medicine Assistant Professor of The Dartmouth Institute, Geisel School of Medicine Registration There is no fee for this activity, but to receive credit you must register online and complete the online evaluation (you must register to access). Learning Outcome(s) Based on the 2018 American Diabetes Association Standards of Medical Care in Diabetes, learners will be able to formulate and implement best practice treatment modalities when caring for patients with diabetes. Accreditation Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Dartmouth-Hitchcock designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Requirements for Successful Completion In order to receive credit for this Continuing Medical Education (CME) activity, you must: View the entire presentation Complete the activity evaluation. (you must register to access). Speaker Disclosure The Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for 2018 Diabetes Guideline Update: Controversies and New Recommendations have reported NO financial interest or relationship* which could be perceived as a real or apparent conflict of interest. There were no individuals in a position to control the content that refused to disclose. In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity. *A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy. Provider Contact Information Provider contact information for questions regarding accreditation of the activity: Center for Learning and Professional Development Dartmouth-Hitchcock Medical Center clpd.support@hitchcock.org For more information on this topic, please go to: http://www.diabetes.org/newsroom/press-releases/2017/american-diabetes-association-2018-release-standards-of-medical-care-in-diabetes.html Type: Internet Activity (Enduring Material) Resume 24 Registered Users Credits 0.75 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit™ ACCME > AMA PRA Category 1 Credit™ Available: 0.75 Credits Earned: 0 Credits Release Date: 4/12/2018 Expiration Date: 4/12/2019
